Home/Filings/4/0001683168-22-008722
4//SEC Filing

White Chad Norman 4

Accession 0001683168-22-008722

CIK 0001367083other

Filed

Dec 29, 7:00 PM ET

Accepted

Dec 30, 5:02 PM ET

Size

5.5 KB

Accession

0001683168-22-008722

Insider Transaction Report

Form 4
Period: 2022-12-29
White Chad Norman
Chief Financial Officer
Transactions
  • Award

    Stock option (right to buy)

    2022-12-29+9,75314,753 total
    Exercise: $1.08Exp: 2032-12-29Common Stock (9,753 underlying)
Footnotes (2)
  • [F1]The options vest one third each on 12/29/2023, 12/29/2024 and 12/29/2025, or upon change of control.
  • [F2]The options were awarded and granted to Mr. White for services performed as part of the Company's annual grant of stock options.

Documents

1 file

Issuer

Sonoma Pharmaceuticals, Inc.

CIK 0001367083

Entity typeother

Related Parties

1
  • filerCIK 0001949607

Filing Metadata

Form type
4
Filed
Dec 29, 7:00 PM ET
Accepted
Dec 30, 5:02 PM ET
Size
5.5 KB